Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #213
- Final score
- 61.03
- Years on list
- 6
↗ Climbed 106 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 106 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 401 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 247 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | WAT | MRNA | QGEN |
|---|---|---|---|
| Climate Change | 74.8 | 77.8 | 77.6 |
| Employee Relations | 47.2 | 47.7 | 53.9 |
| Environment | 64.4 | 50.8 | 57.2 |
| Stakeholders & Society | 80.6 | 83.9 | 45.6 |
| Human Rights | 42.2 | 60.4 | 59.0 |
| Governance | 47.2 | 50.8 | 54.5 |
| Performance Rating | 55.2 | 64.1 | 64.4 |